Purinergic contraction of the rat vas deferens in L-NAME-induced hypertension: effect of sildenafil.
Gur
Serap
S
Department of Urology, Tulane University Health Sciences Center, New Orleans, LA 70112, USA.
Sikka
Suresh C
SC
Knight
Gillian E
GE
Burnstock
Geoffrey
G
Hellstrom
Wayne J G
WJ
D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D004558:Electric Stimulation; D004791:Enzyme Inhibitors / Q000633:toxicity*; D006973:Hypertension / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D019331:NG-Nitroarginine Methyl Ester / Q000633:toxicity*; D010656:Phenylephrine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology*; D058910:Purinergic P2 Receptor Agonists; D058919:Purinergic P2 Receptor Antagonists; D011687:Purines / Q000494:pharmacology; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018048:Receptors, Purinergic P2 / Q000378:metabolism; D058469:Receptors, Purinergic P2X; D058477:Receptors, Purinergic P2X3; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000494:pharmacology*; D014649:Vas Deferens / Q000187:drug effects* / Q000502:physiology; D014665:Vasodilator Agents / Q000494:pharmacology*
D004791:Enzyme Inhibitors; C546410:P2rx3 protein, rat; D010879:Piperazines; D058910:Purinergic P2 Receptor Agonists; D058919:Purinergic P2 Receptor Antagonists; D011687:Purines; D018048:Receptors, Purinergic P2; D058469:Receptors, Purinergic P2X; D058477:Receptors, Purinergic P2X3; D013450:Sulfones; D014665:Vasodilator Agents; C077792:pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid; D010656:Phenylephrine; D011732:Pyridoxal Phosphate; D000255:Adenosine Triphosphate; D000068677:Sildenafil Citrate; C002630:alpha,beta-methyleneadenosine 5'-triphosphate; D019331:NG-Nitroarginine Methyl Ester